Thomas Newsom-Davis, PhD
Enriched profileMedical Oncologist, Chelsea and Westminster Hospital NHS Foundation Trust · Chelsea and Westminster Hospital NHS Foundation Trust
Thomas Newsom-Davis is Medical Oncologist, Chelsea and Westminster Hospital NHS Foundation Trust at Chelsea and Westminster Hospital NHS Foundation Trust. OpenAlex indexes 115 publications with 3,489 citations (h-index 25).
Data verified 9 Nov 2026
Overview
Updated 10 Nov 2026
Thomas Newsom-Davis is Medical Oncologist, Chelsea and Westminster Hospital NHS Foundation Trust. The public record shows 115 publications with 3,489 citations (h-index 25), centered on Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers.
- Most recent indexed publication: 2023 · BMJ open
- Top research focus: Lung Cancer Diagnosis and Treatment
Generated from the cited public record · current as of 10 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 1 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 34.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 9 Nov 2026
18 congress contributions (2004–2025) across AACR, ASCO, ESMO, EULAR, IASLC per OpenAlex. The most recent:
- 2564P Impact of mental health diagnoses on accessing rapid diagnostic cancer centres
ESMO Congress
ESMO2025Co-authorPoster - 1541P Real-world data of atezolizumab plus carboplatin-etoposide for patients with extensive stage SCLC: The UK experience
ESMO Congress
ESMO2022Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 9 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗
Editorial & leadership roles
journal and society appointments- Chair
British Thoracic Oncology Group (BTOG) Steering Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lungsummit.org ↗ - Vice Chair
British Thoracic Oncology Group (BTOG) Steering Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗ - Vice-Chair
IASLC Multidisciplinary Clinical Science Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lungsummit.org ↗ - Chair
HCA Healthcare UK Thoracic Oncology Board
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗ - Chair
Harley Street Clinic lung cancer multidisciplinary team
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eacts.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Bower
Chelsea and Westminster Hospital NHS Foundation Trust
Anton Pozniak
Chelsea and Westminster Hospital NHS Foundation Trust
Mark Richard Johnson
Chelsea and Westminster Hospital NHS Foundation Trust
Marta Boffito
Chelsea and Westminster Hospital NHS Foundation Trust
Ignacio Wistuba, MD
Moffitt Cancer Center
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)